Medicaid Provider SpendingClaims paid 2018–2024 · HHS public file
Home › SC › Columbia › NPI 1154373843
Hospital

Prisma Health-Midlands

Prisma Health-Midlands was paid $74.58M by Medicaid between Jan 2018 and Dec 2024, across 486 billing codes. Its largest line is 36415, Collection of venous blood by venipuncture — 9.9% of everything it billed.

33Billing provider infoPRISMA HEALTH-MIDLANDS
COLUMBIA, SC 29203
33aNPI1154373843assigned 05/17/2006
33bProvider typeGeneral Acute Care Hospital
28Total paid$74.58M
24GClaims1,294,731
24DCodes billed486
24AFirst – last monthJan 2018 – Dec 2024
Compared with peers

Next to other General Acute Care Hospital providers in South Carolina

Rank by total paid#4 of 115
Median peer was paid$2.47M
This provider vs. median30×

Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.

Auditor's notes

Automated statistical signals. Not evidence of fraud — how these are computed.

Entity ProliferationAuthorized official MILLER, POLLY controls 20+ related entities in our dataset. Read more
Box 24A · Dates of service

Paid by month

$0$1.0M$2.0M$3.0M2018201920202021202220232024
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
YearClaimsPaid
2018128,742$7.31M
2019163,631$8.41M
2020202,594$9.40M
2021244,441$12.03M
2022233,398$13.58M
2023179,265$12.65M
2024incomplete142,660$11.21M
Box 24 · Service lines

What it billed for

CodeServiceShareClaimsBene. recordsPaid
36415 Collection of venous blood by venipuncture 9.9% 39,840 35,108 $7.39M
97110 Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion 5.8% 61,026 20,186 $4.31M
81025 5.2% 16,078 15,455 $3.88M
99283 Emergency room visit (moderate)Emergency department visit for the evaluation and management, moderate severity 5.0% 50,115 46,981 $3.74M
80048 Basic metabolic panel (calcium, ionized) 4.2% 25,475 22,198 $3.16M
96374 Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance 3.8% 10,353 9,570 $2.86M
80053 Comprehensive metabolic panel 3.5% 29,762 26,738 $2.61M
99282 Emergency department visit for the evaluation and management, low to moderate severity 2.9% 13,927 13,108 $2.14M
70553 Magnetic resonance imaging, brain; without contrast material, followed by contrast material and further sequences 2.8% 1,779 1,764 $2.12M
96372 Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular 2.6% 12,898 9,906 $1.92M
99212 Office or other outpatient visit for the evaluation and management of an established patient, straightforward 2.5% 26,132 23,221 $1.84M
G0463 Hospital outpatient clinic visit for assessment and management of a patient 2.3% 28,801 23,717 $1.73M
474 more codes
81003 2.3% 17,051 $1.68M
96361 Intravenous infusion, hydration; each additional hour 2.2% 12,823 $1.67M
C9803 Hospital outpatient clinic visit specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source 1.9% 9,021 $1.39M
0241U Neonatal screening for hereditary disorders, genomic sequence analysis panel 1.6% 9,366 $1.21M
93306 Echocardiography, transthoracic, real-time with image documentation, with and without Doppler, complete 1.6% 3,897 $1.17M
70551 Magnetic resonance imaging, brain; without contrast material 1.5% 1,737 $1.14M
96365 Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour 1.3% 7,486 $943K
88305 Level IV - Surgical pathology, gross and microscopic examination 1.3% 4,044 $936K
95810 Polysomnography; sleep staging with 4 or more additional parameters 1.3% 1,843 $933K
99211 Office or other outpatient visit for the evaluation and management of an established patient, minimal severity 1.2% 10,053 $897K
86850 1.2% 6,213 $884K
99284 Emergency room visit (serious) 1.1% 23,840 $796K
88304 1.1% 2,254 $789K
71046 Radiologic examination, chest; 2 views <1% 15,733 $708K
99213 Doctor's office visit, returning patient (routine) <1% 15,077 $694K
87491 Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe <1% 15,757 $645K
96360 Intravenous infusion, hydration; initial, 31 minutes to 1 hour <1% 4,824 $619K
92507 Treatment of speech, language, voice, communication, and/or auditory processing disorder <1% 8,269 $616K
97530 Therapeutic activities, direct patient contact, each 15 minutes <1% 10,885 $587K
84156 <1% 1,622 $577K
97161 <1% 8,176 $570K
81001 <1% 22,650 $465K
87086 Culture, bacterial; quantitative colony count, urine <1% 13,265 $436K
99281 Emergency department visit for the evaluation and management, self-limited or minor <1% 2,499 $403K
99391 Periodic comprehensive preventive medicine reevaluation, established patient, infant (under 1 year) <1% 3,925 $390K
99285 Emergency room visit (most serious) <1% 14,815 $374K
95782 <1% 378 $355K
80069 <1% 4,022 $346K
70450 Computed tomography, head or brain; without contrast material <1% 4,694 $319K
87480 <1% 3,054 $299K
54360 <1% 680 $288K
84702 <1% 4,226 $282K
85027 <1% 10,842 $281K
74018 <1% 4,756 $270K
78452 Myocardial perfusion imaging, tomographic (SPECT); multiple studies at rest and/or stress <1% 417 $269K
76770 <1% 1,753 $269K
87081 <1% 5,948 $269K
87804 Infectious agent antigen detection by immunoassay; Influenza, each type <1% 1,827 $268K
82306 Vitamin D; 25 hydroxy, includes fraction(s), if performed <1% 6,091 $268K
99214 Doctor's office visit, returning patient (more involved) <1% 5,011 $263K
87070 <1% 1,728 $262K
85025 Blood count; complete (CBC), automated, and automated differential WBC count <1% 49,974 $252K
99392 Periodic comprehensive preventive medicine reevaluation, established patient, early childhood (1-4 years) <1% 4,378 $250K
87481 <1% 602 $248K
80307 Drug test(s), presumptive, any number of drug classes; immunoassay <1% 5,635 $248K
92551 <1% 3,266 $246K
87210 <1% 3,379 $242K
96366 Intravenous infusion, for therapy, prophylaxis, or diagnosis; each additional hour <1% 3,026 $227K
76830 Ultrasound, transvaginal <1% 1,310 $217K
76705 Ultrasound, abdominal, real time with image documentation; limited <1% 3,044 $205K
U0003 Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r <1% 9,004 $196K
95700 <1% 606 $191K
76700 Ultrasound, abdominal, real time with image documentation; complete <1% 885 $190K
86900 <1% 6,832 $185K
99393 Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years) <1% 3,988 $178K
D2930 Prefabricated stainless steel crown - primary tooth <1% 299 $177K
96375 Therapeutic injection; each additional sequential IV push <1% 7,032 $171K
87077 <1% 4,556 $169K
82657 <1% 216 $168K
69436 Tympanostomy (requiring insertion of ventilating tube), general anesthesia <1% 696 $161K
87651 Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe <1% 2,380 $161K
99394 Periodic comprehensive preventive medicine reevaluation, established patient, adolescent (12-17 years) <1% 3,264 $161K
93005 Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report <1% 14,869 $158K
73130 <1% 1,693 $158K
80061 Lipid panel <1% 9,358 $156K
76816 Ultrasound, pregnant uterus, real time with image documentation, follow-up <1% 1,793 $155K
36416 <1% 1,205 $154K
G0378 Hospital observation service, per hour <1% 12,650 $153K
71045 Radiologic examination, chest; single view <1% 6,712 $151K
85018 <1% 2,986 $151K
83655 <1% 2,042 $133K
74177 Computed tomography, abdomen and pelvis; with contrast material <1% 2,830 $131K
93010 Electrocardiogram, routine ECG with at least 12 leads; interpretation and report only <1% 23,776 $130K
42820 Tonsillectomy and adenoidectomy; younger than age 12 <1% 1,221 $123K
93971 <1% 352 $118K
85347 <1% 440 $118K
77063 Screening digital breast tomosynthesis, bilateral <1% 894 $117K
73721 Magnetic resonance imaging, any joint of lower extremity; without contrast material <1% 116 $113K
83036 Hemoglobin; glycosylated (A1C) <1% 9,403 $102K
73630 <1% 1,698 $101K
86780 <1% 7,668 $97K
73560 <1% 1,681 $91K
87389 Infectious agent antigen detection by immunoassay technique, HIV-1 antigen with HIV-1 and HIV-2 antibodies <1% 8,765 $87K
93017 <1% 989 $86K
73030 <1% 1,106 $84K
96376 <1% 4,382 $84K
99202 Office or other outpatient visit for the evaluation and management of a new patient, straightforward <1% 1,443 $82K
73610 <1% 1,073 $81K
82565 <1% 423 $80K
77067 Screening mammography, bilateral, including computer-aided detection <1% 2,412 $79K
93922 <1% 156 $78K
87880 Infectious agent antigen detection by immunoassay; Streptococcus, group A <1% 1,972 $77K
76937 <1% 1,187 $77K
87624 Infectious agent detection by nucleic acid; human papillomavirus (HPV), high-risk types <1% 1,546 $72K
97165 <1% 1,323 $72K
12011 <1% 295 $69K
94640 Pressurized or nonpressurized inhalation treatment for acute airway obstruction <1% 5,725 $69K
87635 Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe <1% 2,249 $67K
76856 Ultrasound, pelvic (nonobstetric), real time with image documentation; complete <1% 1,145 $64K
95806 <1% 297 $63K
71260 Computed tomography, thorax, diagnostic; with contrast material <1% 549 $58K
73110 <1% 719 $58K
72100 <1% 1,044 $57K
95811 <1% 151 $53K
54161 <1% 356 $51K
J7120 Ringers lactate infusion, up to 1000 cc <1% 23,023 $48K
72040 <1% 564 $48K
88300 <1% 122 $48K
85610 <1% 6,742 $45K
87637 Infectious agent detection by nucleic acid; SARS-CoV-2, influenza, and RSV <1% 510 $45K
76811 Ultrasound, pregnant uterus, real time with image documentation, fetal and maternal evaluation, detailed <1% 236 $44K
73090 <1% 415 $44K
95951 <1% 211 $43K
43239 Esophagogastroduodenoscopy, flexible, transoral; with biopsy, single or multiple <1% 1,629 $42K
82043 <1% 2,423 $41K
86140 <1% 5,091 $40K
U0005 Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2 <1% 1,505 $38K
87502 Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets <1% 397 $38K
71275 Computed tomographic angiography, chest, with contrast material <1% 759 $37K
95957 <1% 423 $35K
72125 Computed tomography, cervical spine; without contrast material <1% 1,140 $35K
80074 <1% 1,162 $34K
87428 <1% 275 $33K
71250 <1% 84 $33K
84703 <1% 598 $33K
97140 Manual therapy techniques, each 15 minutes (e.g., mobilization/manipulation, manual lymphatic drainage) <1% 3,409 $32K
72148 Magnetic resonance imaging, lumbar spine; without contrast material <1% 79 $32K
97535 Self-care/home management training, each 15 minutes <1% 1,025 $32K
74019 <1% 753 $31K
84443 Thyroid stimulating hormone (TSH) <1% 9,444 $30K
95813 <1% 109 $30K
80076 <1% 1,936 $29K
83735 <1% 13,091 $29K
86902 <1% 945 $28K
92523 <1% 353 $28K
J3490 Unclassified drugs <1% 6,990 $27K
0202U Oncology (prostate), multianalyte, gene expression profiling <1% 177 $25K
92526 <1% 391 $25K
73590 <1% 420 $25K
93888 <1% 141 $24K
76536 <1% 189 $24K
82728 <1% 3,260 $24K
12001 <1% 122 $24K
82950 <1% 2,668 $24K
59025 Fetal non-stress test <1% 714 $24K
97162 <1% 510 $23K
84439 <1% 2,570 $23K
76642 <1% 300 $21K
76805 Ultrasound, pregnant uterus, real time with image documentation, fetal and maternal evaluation <1% 141 $20K
41899 Unlisted procedure, dentoalveolar structures <1% 421 $19K
94760 <1% 1,306 $18K
70496 <1% 80 $18K
84145 <1% 2,263 $18K
76886 <1% 102 $18K
84484 <1% 7,057 $18K
J7030 Infusion, normal saline solution , 1000 cc <1% 5,472 $17K
73502 <1% 334 $17K
76815 Ultrasound, pregnant uterus, real time with image documentation, limited <1% 379 $17K
76376 <1% 42 $17K
93880 <1% 56 $17K
76000 <1% 423 $17K
99215 Doctor's office visit, returning patient (complex) <1% 646 $16K
85014 <1% 653 $16K
76801 <1% 650 $16K
C8929 Transthoracic echocardiography with contrast, or without contrast followed by with contrast, real-time with image documentation (2d), includes m-mode recording, when performed, complete, with spectral doppler echocardiography, and with color flow doppler echocardiography <1% 85 $16K
85660 <1% 755 $16K
87807 <1% 284 $15K
P9016 Red blood cells, leukocytes reduced, each unit <1% 1,075 $15K
82330 <1% 415 $15K
42830 <1% 53 $15K
A4649 Surgical supply; miscellaneous <1% 175 $15K
88142 <1% 1,494 $15K
87631 <1% 1,230 $14K
82570 <1% 4,014 $14K
99203 Doctor's office visit, new patient (routine) <1% 163 $14K
76818 <1% 444 $14K
99174 <1% 200 $14K
74230 <1% 49 $14K
76870 <1% 66 $13K
77072 <1% 374 $13K
93923 <1% 39 $13K
72141 <1% 12 $12K
90686 <1% 6,389 $12K
93970 <1% 40 $12K
J1100 Injection, dexamethasone sodium phosphate, 1 mg <1% 13,027 $12K
J3010 Injection, fentanyl citrate, 0.1 mg <1% 14,868 $11K
J2270 Injection, morphine sulfate, up to 10 mg <1% 3,866 $11K
J2704 Injection, propofol, 10 mg <1% 2,223 $11K
J2405 Injection, ondansetron hydrochloride, per 1 mg <1% 16,135 $11K
82550 <1% 1,575 $11K
0002A <1% 288 $10K
Q9967 Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml <1% 4,533 $10K
76885 <1% 64 $10K
73070 <1% 59 $10K
83020 <1% 3,372 $9K
83001 <1% 321 $9K
S5010 5% dextrose and 0.45% normal saline, 1000 ml <1% 1,452 $8K
S9445 Patient education, not otherwise classified, non-physician provider, individual, per session <1% 66 $8K
82105 <1% 418 $8K
10060 <1% 38 $8K
70360 <1% 69 $8K
93976 <1% 1,601 $8K
76817 Ultrasound, pregnant uterus, real time with image documentation, transvaginal <1% 781 $8K
0072A <1% 220 $8K
97112 Therapeutic procedure, each 15 minutes; neuromuscular reeducation of movement, balance, coordination <1% 387 $7K
G0145 Screening cytopathology, cervical or vaginal (any reporting system), collected in preservative fluid, automated thin layer preparation, with screening by automated system and manual rescreening under physician supervision <1% 650 $7K
84146 <1% 293 $7K
87426 Infectious agent antigen detection, SARS-CoV-2 (COVID-19) <1% 70 $7K
86361 <1% 487 $7K
86706 <1% 393 $6K
99204 Doctor's office visit, new patient (more involved) <1% 76 $6K
82272 <1% 132 $6K
90715 <1% 3,602 $6K
90460 Immunization administration through 18 years of age via any route, first or only component <1% 12,335 $6K
87661 Infectious agent detection by nucleic acid; Trichomonas vaginalis, amplified probe <1% 10,698 $6K
96367 <1% 174 $6K
J1815 Injection, insulin, per 5 units <1% 574 $6K
82805 <1% 381 $6K
82607 <1% 1,316 $6K
69209 <1% 52 $5K
86901 <1% 6,842 $5K
J7040 Infusion, normal saline solution, sterile (500 ml = 1 unit) <1% 3,517 $5K
S0315 Disease management program; initial assessment and initiation of the program <1% 146 $5K
82962 <1% 131 $5K
80177 <1% 171 $5K
87040 <1% 2,020 $5K
83037 <1% 96 $5K
76819 Fetal biophysical profile; without non-stress testing <1% 541 $5K
86038 <1% 414 $5K
70250 <1% 12 $5K
86592 <1% 342 $5K
85045 <1% 8,179 $5K
87205 <1% 1,713 $5K
J1885 Injection, ketorolac tromethamine, per 15 mg <1% 8,075 $5K
99188 <1% 1,187 $5K
73552 <1% 71 $4K
74176 Computed tomography, abdomen and pelvis; without contrast material <1% 39 $4K
82040 <1% 43 $4K
43762 <1% 27 $4K
73080 <1% 28 $4K
85651 <1% 88 $4K
83540 <1% 2,409 $4K
11981 <1% 24 $4K
94664 <1% 1,482 $4K
U0002 2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc <1% 61 $4K
90647 <1% 2,372 $3K
J0696 Injection, ceftriaxone sodium, per 250 mg <1% 3,638 $3K
99173 <1% 867 $3K
83880 <1% 2,356 $3K
92610 <1% 105 $3K
86695 <1% 42 $3K
84132 <1% 368 $3K
84466 <1% 1,887 $3K
82670 <1% 83 $3K
J2060 Injection, lorazepam, 2 mg <1% 982 $3K
85379 <1% 513 $3K
J1650 Injection, enoxaparin sodium, 10 mg <1% 470 $3K
74022 <1% 89 $3K
84134 <1% 561 $3K
86803 <1% 4,388 $3K
0001A <1% 366 $3K
87591 Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe <1% 15,442 $3K
90656 <1% 499 $3K
90670 <1% 2,905 $3K
A9585 Injection, gadobutrol, 0.1 ml <1% 1,203 $3K
99205 Prolong outpt/office vis <1% 116 $2K
G0123 Screening cytopathology, cervical or vaginal (any reporting system), collected in preservative fluid, automated thin layer preparation, screening by cytotechnologist under physician supervision <1% 85 $2K
A9500 Technetium tc-99m sestamibi, diagnostic, per study dose <1% 272 $2K
97116 <1% 436 $2K
87486 <1% 25 $2K
0071A <1% 315 $2K
90677 <1% 736 $2K
J1642 Injection, heparin sodium, (heparin lock flush), per 10 units <1% 1,217 $2K
72170 <1% 55 $2K
84425 <1% 737 $2K
97113 <1% 30 $2K
76377 <1% 17 $2K
J1050 Injection, medroxyprogesterone acetate, 1 mg <1% 4,038 $2K
97597 <1% 73 $2K
99291 Critical care, evaluation and management of the critically ill patient, first 30-74 minutes <1% 105 $2K
J3475 Injection, magnesium sulfate, per 500 mg <1% 753 $2K
93297 <1% 12 $2K
86480 <1% 275 $2K
73060 <1% 12 $2K
85730 <1% 3,246 $2K
90633 <1% 2,627 $2K
J2550 Injection, promethazine hcl, up to 50 mg <1% 640 $2K
80081 <1% 66 $2K
74240 <1% 12 $2K
83690 <1% 5,970 $2K
J1170 Injection, hydromorphone, up to 4 mg <1% 3,866 $2K
J7042 5% dextrose/normal saline (500 ml = 1 unit) <1% 451 $1K
0082A <1% 47 $1K
83516 <1% 341 $1K
85384 <1% 194 $1K
70498 <1% 76 $1K
90471 Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine <1% 5,018 $1K
87536 <1% 553 $1K
Q3014 Telehealth originating site facility fee <1% 29 $1K
74220 <1% 12 $1K
Q9957 Injection, perflutren lipid microspheres, per ml <1% 160 $1K
82077 <1% 490 $993.30
J7050 Infusion, normal saline solution, 250 cc <1% 1,889 $956.15
J3480 Injection, potassium chloride, per 2 meq <1% 737 $954.64
J1200 Injection, diphenhydramine hcl, up to 50 mg <1% 1,544 $931.89
90651 <1% 1,180 $931.48
84100 <1% 2,299 $912.22
84481 <1% 432 $869.80
91320 <1% 188 $853.81
87660 <1% 2,979 $820.08
86580 <1% 52 $813.70
90472 Immunization administration, each additional vaccine (list separately) <1% 218 $812.26
87340 <1% 3,963 $742.28
83605 <1% 1,229 $714.91
0004A <1% 128 $710.34
86308 <1% 14 $697.91
92522 <1% 12 $684.77
G0257 Unscheduled or emergency dialysis treatment for an esrd patient in a hospital outpatient department that is not certified as an esrd facility <1% 235 $672.81
82784 <1% 597 $660.39
94644 <1% 745 $634.69
J2250 Injection, midazolam hydrochloride, per 1 mg <1% 6,111 $613.57
0124A <1% 274 $604.46
87522 Neg quan hep c or qual rna <1% 126 $581.64
J1644 Injection, heparin sodium, per 1000 units <1% 1,353 $559.27
80143 <1% 70 $551.50
58300 <1% 12 $550.82
G1004 Clinical decision support mechanism national decision support company, as defined by the medicare appropriate use criteria program <1% 333 $531.58
86364 <1% 134 $516.25
J0360 Injection, hydralazine hcl, up to 20 mg <1% 30 $498.75
99383 <1% 12 $482.90
86920 <1% 1,211 $482.59
86696 <1% 58 $448.45
86704 <1% 136 $402.18
83615 <1% 1,116 $378.63
90707 <1% 564 $367.90
0054A <1% 134 $360.66
85652 <1% 2,996 $339.84
G8978 Mobility: walking & moving around functional limitation, current status, at therapy episode outset and at reporting intervals <1% 22 $337.66
87075 <1% 132 $336.68
36430 <1% 1,114 $336.53
87186 <1% 3,177 $319.66
J0690 Injection, cefazolin sodium, 500 mg <1% 4,475 $317.94
86762 <1% 1,587 $310.80
82627 <1% 12 $289.77
90620 <1% 512 $288.88
99152 <1% 258 $265.67
82553 <1% 35 $262.80
0081A <1% 105 $261.45
86923 <1% 165 $259.47
90696 <1% 437 $258.04
84550 <1% 220 $254.32
88342 <1% 198 $234.30
82746 <1% 734 $222.39
J2795 Injection, ropivacaine hydrochloride, 1 mg <1% 2,304 $221.51
90700 <1% 478 $184.11
86003 <1% 43 $182.45
J0330 Injection, succinylcholine chloride, up to 20 mg <1% 1,360 $171.30
0052A <1% 14 $166.10
90723 <1% 2,423 $156.00
29125 <1% 12 $140.22
36591 <1% 184 $135.60
84403 <1% 231 $133.50
90746 <1% 29 $119.81
89051 <1% 72 $111.51
80323 <1% 164 $94.94
0154A <1% 43 $81.66
J0171 Injection, adrenalin, epinephrine, 0.1 mg <1% 67 $79.73
J0665 Injection, bupivicaine, not otherwise specified, 0.5 mg <1% 776 $74.02
90710 <1% 610 $55.07
90682 <1% 62 $51.55
86235 <1% 106 $51.16
J0780 Injection, prochlorperazine, up to 10 mg <1% 276 $46.12
82951 <1% 12 $43.76
J2272 Injection, morphine sulfate (fresenius kabi), not therapeutically equivalent to j2270, up to 10 mg <1% 361 $41.74
90734 <1% 1,660 $39.64
H0002 Behavioral health screening to determine eligibility for admission to treatment program <1% 16 $37.60
90681 <1% 1,318 $36.00
86255 <1% 156 $35.71
86787 <1% 76 $32.14
82785 <1% 19 $18.68
84450 <1% 152 $17.87
J2765 Injection, metoclopramide hcl, up to 10 mg <1% 15 $17.62
86317 <1% 35 $13.67
82947 <1% 45 $13.19
J2274 Injection, morphine sulfate, preservative-free for epidural or intrathecal use, 10 mg <1% 152 $11.49
A9270 Non-covered item or service <1% 1,192 $7.98
36410 <1% 155 $4.30
84460 <1% 152 $2.71
G0480 Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 1-7 drug class(es), including metabolite(s) if performed 0% 124 $0.00
J0280 Injection, aminophyllin, up to 250 mg 0% 129 $0.00
87510 0% 3,041 $0.00
90716 0% 549 $0.00
90732 0% 54 $0.00
90480 0% 338 $0.00
45380 Colonoscopy, flexible; with biopsy, single or multiple 0% 243 $0.00
S0020 Injection, bupivicaine hydrochloride, 30 ml 0% 1,420 $0.00
G0472 Hepatitis c antibody screening, for individual at high risk and other covered indication(s) 0% 77 $0.00
88307 0% 26 $0.00
G0008 Administration of influenza virus vaccine 0% 161 $0.00
95716 0% 204 $0.00
86921 0% 138 $0.00
J2371 Injection, phenylephrine hydrochloride, 20 micrograms 0% 54 $0.00
J2785 Injection, regadenoson, 0.1 mg 0% 317 $0.00
83002 0% 184 $0.00
86160 0% 297 $0.00
J1940 Injection, furosemide, up to 20 mg 0% 158 $0.00
70491 0% 13 $0.00
J2003 Injection, lidocaine hydrochloride, 1 mg 0% 150 $0.00
J1630 Injection, haloperidol, up to 5 mg 0% 66 $0.00
C1725 Catheter, transluminal angioplasty, non-laser (may include guidance, infusion/perfusion capability) 0% 41 $0.00
J7298 Levonorgestrel-releasing intrauterine contraceptive system (mirena), 52 mg 0% 12 $0.00
84436 0% 37 $0.00
81050 0% 12 $0.00
J7512 Prednisone, immediate release or delayed release, oral, 1 mg 0% 145 $0.00
99153 Mod sedat endo service >5yrs 0% 56 $0.00
J2370 Injection, phenylephrine hcl, up to 1 ml 0% 251 $0.00
93458 0% 56 $0.00
C1769 Guide wire 0% 300 $0.00
Q9969 Tc-99m from non-highly enriched uranium source, full cost recovery add-on, per study dose 0% 74 $0.00
31231 0% 13 $0.00
86376 0% 88 $0.00
G0379 Direct admission of patient for hospital observation care 0% 76 $0.00
87581 0% 25 $0.00
0051A 0% 14 $0.00
86225 0% 44 $0.00
88341 0% 14 $0.00
90935 Hemodialysis procedure with single evaluation by a physician 0% 23 $0.00
0011A 0% 12 $0.00
87799 0% 612 $0.00
90649 0% 722 $0.00
J0295 Injection, ampicillin sodium/sulbactam sodium, per 1.5 gm 0% 39 $0.00
86922 0% 138 $0.00
90461 0% 2,778 $0.00
90685 0% 612 $0.00
95714 0% 209 $0.00
99395 Periodic comprehensive preventive medicine reevaluation, established patient, 18-39 years 0% 26 $0.00
C1894 Introducer/sheath, other than guiding, other than intracardiac electrophysiological, non-laser 0% 220 $0.00
J2710 Injection, neostigmine methylsulfate, up to 0.5 mg 0% 610 $0.00
93325 0% 16 $0.00
J2930 Injection, methylprednisolone sodium succinate, up to 125 mg 0% 139 $0.00
87512 0% 602 $0.00
C1887 Catheter, guiding (may include infusion/perfusion capability) 0% 46 $0.00
92611 0% 13 $0.00
S0077 Injection, clindamycin phosphate, 300 mg 0% 98 $0.00
80179 0% 40 $0.00
84295 0% 24 $0.00
87798 Infectious agent detection by nucleic acid; not otherwise specified, amplified probe, each organism 0% 26 $0.00
93750 0% 49 $0.00
86200 0% 49 $0.00
J3370 Injection, vancomycin hcl, 500 mg 0% 56 $0.00
90473 0% 12 $0.00
14040 0% 12 $0.00
J1953 Injection, levetiracetam, 10 mg 0% 29 $0.00
J1598 Injection, glycopyrrolate (fresenius kabi), not therapeutically equivalent to j1596, 0.1 mg 0% 66 $0.00
82977 0% 14 $0.00
86431 0% 159 $0.00
J1596 Injection, glycopyrrolate, 0.1 mg 0% 248 $0.00
83970 0% 34 $0.00
82610 0% 12 $0.00
C9113 Injection, pantoprazole sodium, per vial 0% 21 $0.00
90662 0% 20 $0.00
94645 0% 41 $0.00
J2004 Injection, lidocaine hcl with epinephrine, 1 mg 0% 16 $0.00
87633 Infectious agent detection by nucleic acid, respiratory virus, 12-25 targets 0% 25 $0.00
87641 0% 13 $0.00
J2916 Injection, sodium ferric gluconate complex in sucrose injection, 12.5 mg 0% 45 $0.00
G8979 Mobility: walking & moving around functional limitation, projected goal status, at therapy episode outset, at reporting intervals, and at discharge or to end reporting 0% 22 $0.00
J1171 Injection, hydromorphone, 0.1 mg 0% 39 $0.00
J2919 Injection, methylprednisolone sodium succinate, 5 mg 0% 15 $0.00
76857 0% 12 $0.00
C1713 Anchor/screw for opposing bone-to-bone or soft tissue-to-bone (implantable) 0% 13 $0.00
82248 0% 13 $0.00
84590 0% 14 $0.00
88175 Cytopathology, cervical or vaginal, any reporting system; collected in preservative fluid, automated thin layer 0% 25 $0.00

Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.

From NPPES

Who's on the registration

Authorized officialMILLER, POLLY (SVP FINANCE, ENTERPRISE CONTRACTING)
Same official

Other billing entities under MILLER, POLLY

Full network →
ProviderLocationPaid
Prisma Health-MidlandsColumbia, SC$68.26M
Prisma Health-UpstateGreenville, SC$25.04M
Prisma Health-UpstateGreenville, SC$21.98M
Prisma Health-UpstateGreenville, SC$19.69M
Prisma Health-UpstateSeneca, SC$15.64M
Prisma Health-MidlandsColumbia, SC$11.77M
Prisma Health-UpstateGreenville, SC$10.74M
Greenville Health CorporationGreenville, SC$8.90M
Prisma Health-UpstateGreenville, SC$8.32M
Prisma Health-UpstateGreenville, SC$7.45M
Prisma Health University Medical GroupGreenville, SC$7.44M
Prisma Health-MidlandsCoulmbia, SC$7.43M
Prisma Health-MidlandsColumbia, SC$6.88M
Prisma Health TuomeySumter, SC$6.84M
Prisma Health-MidlandsColumbia, SC$6.77M
Prisma Health-UpstateGreenville, SC$6.37M
Prisma Health-UpstateGreenville, SC$5.00M
Prisma Health-UpstateGreenville, SC$4.65M
Prisma Health-MidlandsColumbia, SC$4.63M
Prisma Health-UpstateSeneca, SC$4.48M

Matched on the authorized-official name exactly as entered in NPPES. A common name can match unrelated people.